Source-grounded facts extracted from Ellington Financial Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Ellington Financial Inc. shareholders approved Approval of the Equity Incentive Plan.
“Proposal 4: Approval of the Equity Incentive Plan Votes on a proposal to approve the Equity Incentive Plan were as follows: For Against Abstentions Broker Non-Votes 55,004,182 2,837,889 887,986 33,067,881”
Ellington Financial Inc. shareholders approved Ratification of the Appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accountants at the 2026-12-31 meeting.
“Proposal 3: Ratification of the Appointment of the Company's Independent Registered Public Accountants Votes regarding the proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 were as follows: For Against Abstentions Broker Non-Votes 90,170,282 880,741 746,915 *”
Ellington Financial Inc. shareholders approved Advisory (Non-Binding) Vote to Approve Executive Compensation.
“Proposal 2: Advisory (Non-Binding) “Say on Pay” Vote to Approve Executive Compensation Votes on a proposal to approve, on an advisory basis, the compensation of the Company's named executive officers were as follows: For Against Abstentions Broker Non-Votes 54,695,130 3,273,132 761,795 33,067,881”
Ellington Financial Inc. shareholders approved Election of five directors.
“Proposal 1: Election of Directors Votes regarding the election of five directors, each of whom was elected for a term expiring at the 2027 annual meeting or until such time as his or her successor is elected and qualified, were as follows: For Withheld Broker Non-Votes Stephen J. Dannhauser 48,401,715 10,328,342 33,067,881 Lisa Mumford 56,886,550 1,843,507 33,067,881 Laurence E. Penn 56,661,780 2,068,277 33,067,881 Edward Resendez 55,950,937 2,779,120 33,067,881 Ronald I. Simon, Ph.D. 55,333,825 3,396,232 33,067,881”
Ellington Financial Inc. reported the quarter ended March 31, 2026 results: net income Net income attributable to common stockholders of $95.5 million, or $0.78 per common share., EPS $0.78 per common share.
“Ellington Financial Inc. Reports First Quarter 2026 Results OLD GREENWICH, Connecticut—May 5, 2026 Ellington Financial Inc. (NYSE: EFC) ("we") today reported financial results for the quarter ended March 31, 2026. Highlights • Net income attributable to common stockholders of $95.5 million, or $0.78 per common share.”
Ellington Financial Inc. entered into "Underwriting Agreement" with Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC, as representatives of the several underwriters named therein (effective 2026-01-26).
“On January 26, 2026, Ellington Financial Inc. (the “Company”) and Ellington Financial Management LLC (the “Manager”) entered into an underwriting agreement (the “Underwriting Agreement”) with Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC, as representatives of the several underwriters named therein (the “Underwriters”), relating to the offer and sale of 8,775,000 shares of common stock of the Company, par value $0.001 per share (the “Common Stock”).”
Ellington Financial Inc. entered into Equity Distribution Agreements (amendments and new agreements) with Citizens JMP Securities, LLC, B. Riley Securities, Inc., BTIG, LLC, Armstrong Securities LLC, Citadel Securities Institutional LLC, Moelis & Company LLC valued at Maximum aggregate offering price of up to $500 million of common stock (effective 2025-12-23).
“On December 23, 2025, Ellington Financial Inc. (the “Company”) and Ellington Financial Management LLC, the Company’s manager (the "Manager"), entered into separate amendments (each an "Amendment" and collectively, the "Amendments") to its existing equity distribution agreements dated September 30, 2024 (collectively, as amended, the "Existing Sales Agreements") with each of Citizens JMP Securities, LLC (“Citizens JMP”), B. Riley Securities, Inc. (“B. Riley Securities”), BTIG, LLC (“BTIG”) and Armstrong Securities LLC ("Armstrong") relating to the Company’s previously announced at the market common stock offering program (the “Offering").”
Ellington Financial Inc. incurred senior notes of $400.0 million with qualified institutional buyers and non-U.S. persons at 7.375% maturing September 30, 2030.
“On October 6, 2025, Ellington Financial Operating Partnership LLC, EF Holdco Inc., EF Cayman Holdings Ltd., Ellington Financial REIT Cayman Ltd. and Ellington Financial REIT TRS LLC (the “Issuers”), subsidiaries of Ellington Financial Inc. (the “Company”), issued $400.0 million in aggregate principal amount of 7.375% unsecured senior notes due 2030 (the “Notes”) under an indenture, dated as of October 6, 2025 (the “Indenture”), between the Issuers, the Company and Wilmington Trust, National Association, as trustee.”
Ellington Financial Inc. reported the quarter ended March 31, 2024 results: net income $26.9 million, or $0.32 per common share.
“net income attributable to common stockholders of $26.9 million, or $0.32 per common share.”
Ellington Financial Inc. updated its quarter ended December 31, 2023 guidance (lowered).
“Management expects to recommend to our board of directors a reduction of the monthly dividend from $0.15 to $0.13 per share, beginning in March”
Ellington Financial Inc. reported quarter ended December 31, 2023 results: net income Adjusted Distributable Earnings of $18.9 million, EPS $0.27 per common share.
“Net income attributable to common stockholders of $12.5 million, or $0.18 per common share. 1 ◦ $27.3 million, or $0.38 per common share, from the investment portfolio.”
Ellington Financial Inc.: Filed Certificates of Designations for Series D and Series E Preferred Stock (effective 2023-12-14).
“EFC filed with Secretary of State of the State of Delaware (i) a Certificate of Designations (the “Series D Certificate of Designations”) to designate 379,668 shares of EFC’s authorized preferred stock as shares of EFC Series D Preferred Stock and (ii) a Certificate of Designations (the “Series E Certificate of Designations”) to designate 957,133 shares of EFC’s authorized preferred stock as shares of EFC Series E Preferred Stock, each with an effective date of December 14, 2023.”
Ellington Financial Inc. completed an acquisition involving Arlington Asset Investment Corp. (AAIC) for 0.3619 newly issued shares of EFC Common Stock and $0.09 per share in cash (closed 2023-12-14).
“the Effective Time, which were automatically canceled and retired and ceased to exist as of the Effective Time) was automatically converted into the right to receive: • from EFC, 0.3619 newly issued shares of EFC Common Stock (the “Per Share Stock Consideration”); and • from EFC Manager, a cash amount equal to $0.09 per share (the “Per Share Cash Consideration””
Ellington Financial Inc. amended Amended and Restated Limited Liability Company Operating Agreement with Ellington Financial Operating Partnership LLC valued at A&R Operating Agreement covering issuance of Series D and Series E preferred units, governance chang (effective 2023-12-14).
“On December 14, 2023, immediately following the closing of the Merger, EFC contributed (the “Contribution”) all of the issued and outstanding shares of common stock, par value $0.01 per share, of Merger Sub, to Ellington Financial Operating Partnership LLC (the “Operating Partnership”), in exchange for common units, 7.00% Series D Cumulative Perpetual Redeemable Preferred Units (“Series D Units”) and 8.250% Series E Fixed-to-Floating Rate Cumulative Redeemable Preferred Units (“Series E Units”) of the Operating Partnership. In connection with the Contribution, EFC entered into the Amended and Restated Limited Liability Company Operating Agreement (the “A&R Operating Agreement”) of the Operating Partnership.”
Ellington Financial Inc. amended Amendments to Existing Sales Agreements with Citizens JMP Securities LLC, B. Riley Securities Inc., Ladenburg Thalmann & Co. Inc. valued at Amendments modify Existing Sales Agreements to include UBS and Armstrong as additional sales agents (effective 2023-11-13).
“Also on November 13, 2023, the Company and the Manager entered into amendments (the "Amendments") to each of the equity distribution agreements, dated as of August 6, 2021, as amended on January 24, 2023, by and among the Company and the Manager, on the one hand, and each of Citizens JMP Securities, LLC, B. Riley Securities, Inc., and Ladenburg Thalmann & Co. Inc. (each, an "Agent" and, collectively with UBS and Armstrong, the "Agents"), respectively, on the other hand (as amended, the "Existing Sales Agreements" and, collectively with the UBS Sales Agreement and the Armstrong Sales Agreement, the "Sales Agreements").”
Ellington Financial Inc. entered into Armstrong Sales Agreement with Armstrong Securities LLC valued at common stock offering program with up to $168.33 million Shares available for sale (effective 2023-11-13).
“On November 13, 2023, Ellington Financial Inc. (the “Company”) and Ellington Financial Management LLC, the Company’s manager (the "Manager"), entered into (i) an equity distribution agreement (the “UBS Sales Agreement”) by and among the Company, the Manager and UBS Securities LLC (“UBS” and an "Agent") to include UBS as an additional sales agent in the Company's previously announced at the market common stock offering program and(ii) an equity distribution agreement (the “Armstrong Sales Agreement”) by and among the Company, the Manager and Armstrong Securities LLC (“Armstrong” and an "Agent") to include Armstrong as an additional sales agent in the Company's previously announced at the market common stock offering program.”
Ellington Financial Inc. entered into UBS Sales Agreement with UBS Securities LLC valued at common stock offering program with up to $168.33 million Shares available for sale (effective 2023-11-13).
“On November 13, 2023, Ellington Financial Inc. (the “Company”) and Ellington Financial Management LLC, the Company’s manager (the "Manager"), entered into (i) an equity distribution agreement (the “UBS Sales Agreement”) by and among the Company, the Manager and UBS Securities LLC (“UBS” and an "Agent") to include UBS as an additional sales agent in the Company's previously announced at the market common stock offering program and(ii) an equity distribution agreement (the “Armstrong Sales Agreement”) by and among the Company, the Manager and Armstrong Securities LLC (“Armstrong” and an "Agent") to include Armstrong as an additional sales agent in the Company's previously announced at the market common stock offering program.”
Ellington Financial Inc. reported the quarter ended September 30, 2023 results: net income Net income attributable to common stockholders of $6.6 million, or $0.10 per common share, EPS $0.10 per common share.
“Net income attributable to common stockholders of $6.6 million, or $0.10 per common share.”
Ellington Financial Inc. entered into Purchase Agreement with Great Ajax Corp. valued at approximately $11.0 million (effective 2023-10-20).
“On October 20, 2023, Ellington Financial Inc. (the "Company") entered into a securities purchase agreement (the “Purchase Agreement”) with Great Ajax Corp. (“Great Ajax”), pursuant to which the Company agreed to purchase, and Great Ajax agreed to sell and issue to the Company, in a registered direct offering (the “Registered Offering”), an aggregate of 1,666,666 shares of common stock, $0.01 par value per share, of Great Ajax, at a purchase price per share of $6.60 (the “Shares”). The aggregate proceeds to Great Ajax from the Registered Offering are expected to be approximately $11.0 million”
Ellington Financial Inc. shareholders approved Advisory vote on frequency of say-on-pay votes.
“As previously reported in the Original Form 8-K, the results of the voting were as follows: 1 Year 2 Years 3 Years Abstain Broker Non-Votes 38,695,306 249,535 492,227 362,868 14,874,047”
Ellington Financial Inc. reported the quarter ended June 30, 2023 results: net income $2.9 million, or $0.04 per common share.
“Ellington Financial Inc. Reports Second Quarter 2023 Results”
Ellington Financial Inc. reported the quarter ended June 30, 2023 results: EPS Net income per share of common stock is estimated to be $0.04.
“Ellington Financial Inc. (NYSE: EFC) (the "Company") today disclosed the following estimated book value per share of common stock as of June 30, 2023, and preliminary results of operations for the quarter ended June 30, 2023: • Estimated book value per share of common stock of $14.70 as of June 30, 2023, including the effects of dividends of $0.45 per share of common stock declared during the quarter. • Net income per share of common stock is estimated to be $0.04 for the quarter ended June 30, 2023.”
Ellington Financial Inc. entered into Agreement and Plan of Merger with Great Ajax Corp. (effective 2023-06-30).
“On June 30, 2023, Ellington Financial Inc., a Delaware corporation (“EFC”), EF Acquisition I LLC, a Maryland limited liability company and a direct, wholly-owned subsidiary of EFC (“Merger Sub”), and Great Ajax Corp., a Maryland corporation (“Great Ajax”), entered into an Agreement and Plan of Merger (the “Merger Agreement”)”
Ellington Financial Inc. entered into Agreement and Plan of Merger with Arlington Asset Investment Corp. valued at Merger of Arlington Asset into Merger Sub; consideration includes a fixed exchange ratio of 0.3619 s (effective 2023-05-29).
“On May 29, 2023, Ellington Financial Inc., a Delaware corporation (“EFC”), EF Merger Sub Inc., a Virginia corporation and wholly-owned subsidiary of EFC (“Merger Sub”), Arlington Asset Investment Corp., a Virginia corporation (“Arlington Asset”), and, solely for the limited purposes set forth in the Merger Agreement (as defined below), Ellington Financial Management LLC, a Delaware limited liability company (the “Advisor”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which, subject to the terms and conditions therein, Arlington Asset will be merged with and into Merger Sub, with Merger Sub remaining as a wholly owned subsidiary of EFC (such surviving company, the “Surviving Company,” and such transaction, the “Merger”).”
Ellington Financial Inc. shareholders approved Ratification of the Appointment of the Company's Independent Registered Public Accountants at the 2023-05-16 meeting.
“Proposal 5: Ratification of the Appointment of the Company's Independent Registered Public Accountants Votes regarding the proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023 were as follows: For Against Abstentions Broker Non-Votes 53,946,220 487,396 240,367 * * No broker non-votes arose in connection with this proposal due to the fact that the proposal was considered "routine" under New York Stock Exchange Rules.”
Ellington Financial Inc. shareholders approved Advisory (Non-Binding) "Say on Pay" Vote on Frequency of "Say on Pay' Vote at the 2023-05-16 meeting.
“Proposal 4: Advisory (Non-Binding) "Say on Pay" Vote on Frequency of "Say on Pay' Vote Votes on a proposal on whether an advisory vote on executive compensation should be held every one, two or three years were as follows: 1 Year 2 Years 3 Years Abstain Broker Non-Votes 38,695,306 249,535 492,227 362,868 14,874,047”
Ellington Financial Inc. shareholders approved Advisory (Non-Binding) "Say on Pay" Vote to Approve Executive Compensation at the 2023-05-16 meeting.
“Proposal 3: Advisory (Non-Binding) "Say on Pay" Vote to Approve Executive Compensation Votes on a proposal to approve, on an advisory basis, the compensation of the Company's named executive officers were as follows: For Against Abstentions Broker Non-Votes 34,659,715 4,394,470 745,751 14,874,047”
Ellington Financial Inc. shareholders approved Approval of an Amendment to our Certificate of Incorporation (the "Charter") to Increase the Total Authorized Number of Common Shares for Issuance from 100,000,000 to 200,000,000 shares, with a Corresponding Increase in the Total Authorized Number of Shares from 200,000,000 to 300,000,000 shares at the 2023-05-16 meeting.
“Proposal 2: Approval of an Amendment to our Certificate of Incorporation (the "Charter") to Increase the Total Authorized Number of Common Shares for Issuance from 100,000,000 to 200,000,000 shares, with a Corresponding Increase in the Total Authorized Number of Shares from 200,000,000 to 300,000,000 shares Votes on a proposal to approve an amendment to our Charter to increase the total number of Common Shares for Issuance were as follows: For Against Abstentions Broker Non-Votes 36,217,973 3,257,736 324,227 14,874,047”
Ellington Financial Inc. shareholders approved Election of Directors at the 2023-05-16 meeting.
“Proposal 1: Election of Directors Votes regarding the election of five directors, each of whom was elected for a term expiring at the 2024 annual meeting or until such time as his or her successor is elected and qualified, were as follows: For Withheld Broker Non-Votes Stephen J. Dannhauser 32,040,422 7,762,014 14,874,047 Lisa Mumford 37,741,175 2,061,261 14,874,047 Laurence E. Penn 37,604,550 2,197,886 14,874,047 Edward Resendez 36,972,891 2,829,545 14,874,047 Ronald I. Simon, Ph.D. 36,934,468 2,867,968 14,874,047”
Ellington Financial Inc. reported quarter ended March 31, 2023 results: net income $38.9 million, EPS $0.58 per common share.
“Net income attributable to common stockholders of $38.9 million, or $0.58 per common share.”
Ellington Financial Inc. reported financial results for quarter ended December 31, 2022.
“On February 23, 2023, the Company issued a press release announcing its financial results for the quarter ended December 31, 2022.”
Ellington Financial Inc.: Filed Certificate of Designations establishing terms of 8.625% Series C Fixed-Rate Reset Cumulative Redeemable Preferred Stock, effective February 3, 2023 (effective 2023-02-03).
“On February 3, 2023, the Company filed a Certificate of Designations (the “Certificate of Designations”) with the Secretary of State of the State of Delaware to designate 4,600,000 shares of the Company’s authorized preferred stock as shares of 8.625% Series C Fixed-Rate Reset Cumulative Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of $25.00 per share (“Series C Preferred Stock”), with the designations, powers, rights, preferences, qualifications, limitations and restrictions as set forth in the Certificate of Designations. The Certificate of Designations became effective upon filing on February 3, 2023.”
Ellington Financial Inc. entered into Underwriting Agreement with Piper Sandler & Co. (effective 2023-02-02).
“On February 2, 2023, Ellington Financial Inc. (the “Company”) and Ellington Financial Management LLC (the “Manager”) entered into an underwriting agreement (the “Underwriting Agreement”) with Piper Sandler & Co., as representative of the several underwriters named therein (the “Underwriters”), relating to the offer and sale of 4,000,000 shares of Series C Preferred Stock (as defined below).”
Ellington Financial Inc. reported the quarter ended December 31, 2022 results: EPS estimated to be in the range of $0.36 to $0.38.
“Ellington Financial Inc. (the “Company”) is disclosing certain preliminary results of operations for the quarter ended December 31, 2022 based on currently available information. Preliminary Fourth Quarter Results: • Net income per share of common stock is estimated to be in the range of $0.36 to $0.38 for the quarter ended December 31, 2022.”
Ellington Financial Inc. amended Amendments with JMP Securities LLC, B. Riley Securities, Inc., and Ladenburg Thalmann & Co. Inc. valued at up to $225.0 million (effective 2023-01-24).
“On January 24, 2023, Ellington Financial Inc. (the “Company”) and Ellington Financial Management LLC, the Company’s manager, entered into separate amendments (each an "Amendment" and collectively, the "Amendments") to its existing equity distribution agreements (each, as amended, an "Agreement" and collectively, the "Agreements") with each of JMP Securities LLC, B. Riley Securities, Inc., and Ladenburg Thalmann & Co. Inc. (each an “Agent” and together the “Agents”)”
Ellington Financial Inc.: Amended and Restated Bylaws to update stockholder meeting and proxy rules, including compliance with Rule 14a-19 (effective 2023-01-05).
“On January 5, 2023, the Board of Directors (the “Board”) of Ellington Financial Inc. (the “Company”) approved and adopted the Company’s Amended and Restated Bylaws (the “Amended and Restated Bylaws”) to, among other things, update provisions relating to stockholder meetings to ensure compliance with federal proxy rules, including Rule 14a-19 under the Securities Exchange Act of 1934, as amended.”
Ellington Financial Inc. reported financial results for the quarter ended September 30, 2022.
“On November 7, 2022, the Company issued a press release announcing its financial results for the quarter ended September 30, 2022.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.